Parkside Financial Bank & Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$617K Sell
7,119
-446
-6% -$42.7K 0.05% 225
2025
Q4
$727K Buy
7,565
+643
+9% +$62.5K 0.05% 202
2025
Q3
$659K Sell
6,922
-467
-6% -$42.9K 0.05% 205
2025
Q2
$644K Buy
7,389
+495
+7% +$42K 0.07% 206
2025
Q1
$619K Buy
6,894
+422
+7% +$37.8K 0.08% 184
2024
Q4
$517K Sell
6,472
-59
-0.9% -$5.11K 0.07% 200
2024
Q3
$588K Buy
6,531
+74
+1% +$6.22K 0.08% 175
2024
Q2
$508K Sell
6,457
-542
-8% -$44.4K 0.08% 180
2024
Q1
$610K Buy
6,999
+722
+12% +$61.6K 0.1% 164
2023
Q4
$517K Buy
6,277
+328
+6% +$25K 0.09% 169
2023
Q3
$466K Buy
5,949
+86
+1% +$7.2K 0.11% 145
2023
Q2
$517K Sell
5,863
-745
-11% -$64.1K 0.12% 134
2023
Q1
$533K Buy
6,608
+374
+6% +$30.5K 0.14% 124
2022
Q4
$485K Sell
6,234
-520
-8% -$42.1K 0.14% 120
2022
Q3
$545K Buy
6,754
+670
+11% +$60.2K 0.17% 101
2022
Q2
$547K Sell
6,084
-34
-0.6% -$3.44K 0.17% 110
2022
Q1
$679K Sell
6,118
-170
-3% -$18K 0.18% 88
2021
Q4
$650K Buy
6,288
+1,481
+31% +$171K 0.16% 102
2021
Q3
$603K Buy
4,807
+493
+11% +$63.8K 0.18% 85
2021
Q2
$535K Buy
4,314
+120
+3% +$15.1K 0.15% 95
2021
Q1
$495K Sell
4,194
-85
-2% -$9.96K 0.15% 102
2020
Q4
$501K Buy
4,279
+214
+5% +$23.6K 0.16% 94
2020
Q3
$422K Buy
4,065
+639
+19% +$64.2K 0.15% 98
2020
Q2
$314K Buy
3,426
+273
+9% +$26.2K 0.1% 143
2020
Q1
$284K Buy
3,153
+1,579
+100% +$168K 0.11% 140
2019
Q4
$178K Buy
1,574
+118
+8% +$12.9K 0.05% 202
2019
Q3
$158K Sell
1,456
-32
-2% -$3.34K 0.05% 208
2019
Q2
$145K Buy
1,488
+56
+4% +$5.11K 0.05% 221
2019
Q1
$131K Buy
1,432
+128
+10% +$11.5K 0.04% 222
2018
Q4
$119K Buy
1,304
+139
+12% +$13K 0.04% 227
2018
Q3
$114K Sell
1,165
-32
-3% -$2.96K 0.04% 238
2018
Q2
$102K Buy
1,197
+280
+31% +$23.4K 0.04% 240
2018
Q1
$74K Buy
917
+76
+9% +$6.27K 0.03% 281
2017
Q4
$68K Sell
841
-319
-28% -$25.5K 0.02% 299
2017
Q3
$91K Buy
1,160
+14
+1% +$1.16K 0.04% 237
2017
Q2
$102K Buy
1,146
+210
+22% +$17.7K 0.04% 207
2017
Q1
$76K Buy
936
+23
+3% +$1.8K 0.03% 252
2016
Q4
$65K Sell
913
-1,192
-57% -$93.6K 0.03% 293
2016
Q3
$182K Buy
2,105
+30
+1% +$2.61K 0.08% 166
2016
Q2
$180K Sell
2,075
-120
-5% -$9.7K 0.09% 155
2016
Q1
$165K Buy
2,195
+47
+2% +$3.54K 0.08% 164
2015
Q4
$165K Buy
2,148
+80
+4% +$6.02K 0.08% 158
2015
Q3
$139K Sell
2,068
-2,407
-54% -$177K 0.08% 166
2015
Q2
$332K Sell
4,475
-152
-3% -$11.6K 0.18% 111
2015
Q1
$361K Buy
4,627
+518
+13% +$39.3K 0.19% 109
2014
Q4
$297K Buy
4,109
+147
+4% +$10.2K 0.17% 117
2014
Q3
$246K Buy
+3,962
New +$252K 0.15% 139

Other funds holding MDT

Parkside Financial Bank & Trust's MDT Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its Medtronic (MDT) stake by 5.9% in Q1 2026, selling an estimated $42.7K and leaving 7,119 shares worth $617K. The position accounts for 0.05% of the portfolio, ranked #225.

Parkside Financial Bank & Trust first reported a position in MDT in Q3 2014 and has held it in 47 quarters since. The position peaked at $727K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Parkside Financial Bank & Trust held 7,119 shares of Medtronic worth $617K as of Q1 2026.
  • Parkside Financial Bank & Trust sold 446 Medtronic shares in Q1 2026, an estimated $42.7K.
  • Medtronic made up 0.05% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #225 holding.
  • Parkside Financial Bank & Trust first reported a position in Medtronic in Q3 2014 and has held it in 47 quarters since.
  • Parkside Financial Bank & Trust's Medtronic position peaked at $727K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.